期刊文献+

新疆维吾尔族妇女宫颈上皮内瘤变及宫颈鳞癌组织中VEGF-C的表达及意义

The expressions of VEGF-C in cervical intraepithelial neoplasia and cervical squamous carcinoma and its significance in women of Uygur nationality in Xinjiang
原文传递
导出
摘要 目的:探讨新疆维吾尔族妇女宫颈上皮内瘤样病变(CIN)及宫颈癌组织中VEGF-C的表达及其与临床病理特征的关系。方法:应用免疫组化方法检测慢性宫颈炎22例、CIN24例及宫颈癌活检与手术切除43例标本中VEGF-C的表达,并与临床病理参数进行比较分析。结果:慢性宫颈炎、CIN及宫颈癌组中VEGF-C阳性表达率分别为9.1%、87.5%、100.0%,差异有统计学意义(P<0.01);VEGF-C在临床Ⅰ~Ⅱ期和Ⅲ~Ⅳ期宫颈癌组中强阳性表达率分别是44.1%、88.9%,差异有统计学意义(P<0.05);在组织分化1~2级和3级的宫颈癌患者中强阳性表达率分别是51.6%和58.3%,差异无统计学意义(P>0.05);在肿瘤直径≤4cm的宫颈癌组织中的强阳性表达率是40.0%,>4cm的宫颈癌组织中的强阳性表达率是72.2%,差异有统计学意义(P<0.05);CT显示有淋巴结肿大的宫颈癌组织中VEGF-C的阳性表达率是65.5%,高于无淋巴结肿大的宫颈癌组织中的阳性表达率28.6%,差异有统计学意义(P<0.05);早期手术的24例宫颈癌标本中没有淋巴浸润及有淋巴浸润VEGF-C强阳性表达率分别是55.6%和50.0%,差异无统计学意义(P>0.05);在肿瘤浸润宫颈浅肌层与深肌层VEGF-C强阳性表达率分别是50.0%和60.0%,差异无统计学意义(P>0.05)。结论:新疆维吾尔族妇女宫颈癌组织中VEGF-C阳性的表达与临床分期、肿瘤的大小及CT显示淋巴结肿大呈显著相关,与组织学分化、肿瘤浸润的程度及淋巴结的浸润无关。 Objective:To explore the expressions of vascular endothelial growth factor-C(VEGF-C) in cervical intraepithelial neoplasia(CIN) and cervical squamous carcinoma and its relationship with clinicopathological characteristics in women of Uygur nationality in Xinjiang.Methods:Immunohistochemical method was used to detect the expression levels of VEGF-C in 22 samples of chronic cervicitis,24 samples of CIN and 43 samples of cervical squamous carcinoma biopsy and exairesis,and the clinicopathological parameters were compared and analyzed.Results:The positive expression rates of VEGF-C in chronic cervicitis,CIN and cervical carcinoma were 9.1%,87.5% and 100.0%,respectively,there was significant difference(P0.05).The strong positive expression rates of VEGF-C in cervical carcinoma of stage Ⅰ-Ⅱ and stage Ⅲ were 44.1% and 88.9%,respectively,there was significant difference(P0.05);the strong positive expression rates of VEGF-C in cervical carcinoma of grade 1~2 and grade 3 were 51.6% and 58.3%,respectively,there was no significant difference(P0.05);the strong positive expression rates of VEGF-C in cervical carcinoma with diameter≤4 cm and diameter4 cm were 40.0% and 72.2%,respectively,there was significant difference(P0.05);the positive expression rate of VEGF-C in cervical carcinoma with lymphadenectasis was 65.5%,which was significantly higher than that without lymphadenectasis(28.6%)(P0.05).Among 24 cases with cervical squamous carcinoma receiving early operation,the strong positive expression rates of VEGF-C in cervical carcinoma without lymphatic metastasis and with lymphatic metastasis were 55.6% and 50.0%,respectively,there was no significant difference(P0.05);the strong positive expression rates of VEGF-C in cervical carcinoma with superficial muscular layer invasion and deep muscular layer invasion were 50.0% and 60.0%,respectively,there was no significant difference(P0.05).Conclusion:The positive expression of VEGF-C in cervical carcinoma is related to clinical stages,tumor sizes and lymphadenectasis significantly in women of Uygur nationality in Xinjiang,but it is independent of histological differentiation,the depth of tumor invasion and lymphatic metastasis.
出处 《中国妇幼保健》 CAS 北大核心 2010年第31期4588-4591,共4页 Maternal and Child Health Care of China
关键词 维吾尔族 宫颈癌 血管内皮生长因子 免疫组织化学 Uygur Cervical carcinoma Vascular endothelial growth factor Immunohistochemistry
  • 相关文献

参考文献15

  • 1Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF - C, is a ligand for the Fh4 ( VEGFR - 3 ) and KDR (VEGFR - 2) receptor tyrosine kinases [ J) . EMBOJ, 1996, 15 (2): 290.
  • 2Karpanen T, Egeblad M, Karkkainen MI, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth [J]. Cancer Res, 2001, 61 (5) : 1786.
  • 3Sain S, Maria B, Jose A, et al. VEGF - c and VEGFR - 3 expression in human thyroid pathologies [J]. Int J Cancer, 2000, 86 (1) : 47.
  • 4Amioka T, Kitadai Y, Tanaka S, et al. Vascular endothelial growth factor C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa [ J]. Eur J Cancer, 2002, 38 (10) : 1413.
  • 5Kajita T, Ohta Y, Kimura K, et al. The expression of vascular endothelial growth factor - C and it receptors in non - small cell lung cancer [J] .Br J Cancer, 2001, 85 (1) : 255.
  • 6王玉珍,梁志清.血管内皮生长因子C在上皮性卵巢癌的表达与淋巴结转移的关系[J].西北国防医学杂志,2004,25(2):103-105. 被引量:5
  • 7李梅,毛福荣,曹学全,张蕾,陈奎生.VEGF-C在宫颈鳞癌组织中的表达及临床意义[J].肿瘤基础与临床,2007,20(2):127-128. 被引量:5
  • 8王向红,张占薪,张占化,陈奎生.宫颈鳞癌组织中VEGF-C、VEGFR-3的表达变化及意义[J].山东医药,2009,49(26):38-39. 被引量:6
  • 9Fujimoto J, Toyoki H, Sato E, et al. Clinical implication of expression of vascular endothelial growth factor - C in metastatic lymph nodes of uterine cervical cancers [J]. Br J Cancer, 2004, 91 (3) : 466.
  • 10Jach R, Dulinska - Litewka J, Laidler P, et al. Expression of VEGF, VEGF -C and VEGFR-2 in in situ and invasive SCC of cervix [J] . Front Biosci (Elite Ed), 2010, 2:411.

二级参考文献26

  • 1[1]Skobe M,Hawighost T,Jockson DG,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nat Med, 2001, 7(2): 192-198.
  • 2[2]Krishnan J, Kirkin V, Steffen A,et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats[J].Cancer Res, 2003,63(3):713-722.
  • 3[3]Nakashima T, Kondoh S, Kitoh H,et al. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis[J].Int J Mol Med, 2003,11(1):33-39.
  • 4[4]Joukov V, Pajusola K, Yuan J, et al. A novel endothelial growth factor,VEGF-C,is a ligand for the Flt4(VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases[J].EMBO,1996,15(2): 290-298.
  • 5[5]Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor-D(VEGF-D) is a ligand for the tyrosine kinases VEGF receptor-2(Flk1) and VEGF receptor-3(Flt4) [J]. Proc Natl Acad Sci USA ,1998,95(2):548-553.
  • 6[6]Mandriota SJ,Jussila L, Jeltsch M,et al.Vascular endothelial growth factor-c-mediated lymphangiogenesis promotes tumors metastasis[J]. EMBO ,2001,20(4): 672-682.
  • 7[7]Stacker SA,Caesar C,Baldwin ME,et al.VEGF-D promoes the metastatic spread of tumor cells via the lymphatics[J].Nat Med,2001,7(2):186-191.
  • 8[8]Makinen T, Jussila L, Veikkola T, et al.Inhibition of lymphangiogenesis with resulting lyphedema in transgenic mice expressing soluble VEGF receptor-3[J]. Nature Med,2001,7(2):199-205.
  • 9[9]Salven P,Lymboussaki A,Heikkila,et al.Vascular endothelial growth factor VEGF-B and VEGF-C are expressed in human tumors[J].Am J Pathol,1998,153(1):103-108.
  • 10Niki T,Iba S,Tokunou M,et al.Expression of vascular endothelial growth factor A,B,C and D and their relationships to lymphnode status in lung adenocarcinoma[J].Clin Cancer Res,2000,6 (6):2431-2439.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部